Could a smartphone app help prevent breast cancer? researchers begin testing
NCT ID NCT07190066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing an early version of the MELIORA app, designed to help women adopt healthier habits like more physical activity, better diet, and less alcohol. About 300 women from four countries—including those at higher risk, current patients, and survivors—will use the app for 14 days and give feedback. The goal is to improve the app's usability and educational content before a larger trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MELIORA digital app (behavioral intervention for physical activity, diet, and alcohol reduction)
What this could lead to
If successful, this pilot will help refine a digital tool that could support healthier lifestyles and potentially lower breast cancer risk.
What could go wrong
This is a very early, small usability test (14 days, 300 participants) focused on app feedback, not on health outcomes. The app may not ultimately reduce cancer risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bröstcancerföreningen Amazona I Stockholms Län (Amazona)
RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fundación Para El Fomento de La Investigación Sanitaria Y Biomédica de La Comunitat Valenciana (Fisabio)
RECRUITINGValencia, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Harokopio University
RECRUITINGAthens, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INCLIVA - Instituto de Investigación Sanitaria
RECRUITINGValencia, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karolinska Institutet
RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lietuvos Sveikatos Mokslų Universitetas (Lsmu)
RECRUITINGKaunas, Lithuania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pagalbos Onkologiniams Ligoniams Asociacija (Pola L T)
RECRUITINGKaunas, Lithuania
Contact Phone: •••-•••-•••• Email: •••••@•••••